Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
07.11.23
/
50%
€357.80
Target price
07.11.24
€388.11
Performance (%)
30.65%
End price
08.11.24
€467.45
Summary
This prediction ended on 08.11.24 with a price of €467.45. With a performance of 30.65% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.141% | 1.141% | -13.780% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $389.00 to $415.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€349.95
05.08.25
05.08.25
€458.50
05.08.26
05.08.26
7.63%
14.04.26
14.04.26
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.90
20.12.24
20.12.24
€498.52
20.12.25
20.12.25
2.55%
21.12.25
21.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
-6.79%
01.06.25
01.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
35.94%
03.08.24
03.08.24